Pharma Journalist 8903 posts 0 comments

Surrozen, Inc. announced that it has entered into a collaboration and license agreement with Boehringer Ingelheim to research and develop SZN-413 for the treatment of retinal diseases.…
Read More...

Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of tirzepatide for the treatment of adults with…
Read More...

Sanofi US has announced it has entered into a co-promotion service agreement with Provention Bio, Inc., for the commercialization of teplizumab in the United States. Teplizumab,…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic,…
Read More...

SAE Media Group reports: The 2nd annual Transdermal and Microneedle Drug Delivery conference has been announced to take place on January 2023. After the first successful year SAE…
Read More...

SAE Media Group reports: The 15th annual Pre-Filled Syringes and Injectable Drug Devices conference will be in January 2023 with a key focus on the future of Drug Delivery and product…
Read More...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that its Life Science business sector…
Read More...

Tempus announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical stage biopharmaceutical company, in support of its ongoing Phase…
Read More...

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today issued the following announcement regarding data from two real-world evidence studies…
Read More...

Enzo Biochem, Inc. announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York. The launch event…
Read More...